Synthesis and Preclinical Evaluation of Urea-Based Prostate-Specific Membrane Antigen-Targeted Conjugates Labeled with 177Lu
AE Machulkin, SA Petrov, V Bodenko… - ACS pharmacology & …, 2024 - ACS Publications
177Lu-labeled small-molecule prostate-specific membrane antigen (PSMA) targeted tracers
are therapeutic agents for metastatic castration-resistant prostate cancer. Optimizing …
are therapeutic agents for metastatic castration-resistant prostate cancer. Optimizing …
Synthesis and Preclinical Evaluation of Urea-Based Prostate-Specific Membrane Antigen-Targeted Conjugates Labeled with 177Lu
AE Machulkin, SA Petrov, V Bodenko… - ACS …, 2024 - pubmed.ncbi.nlm.nih.gov
177 Lu-labeled small-molecule prostate-specific membrane antigen (PSMA) targeted tracers
are therapeutic agents for metastatic castration-resistant prostate cancer. Optimizing …
are therapeutic agents for metastatic castration-resistant prostate cancer. Optimizing …
Synthesis and Preclinical Evaluation of Urea-Based Prostate-Specific Membrane Antigen-Targeted Conjugates Labeled with 177Lu.
AE Machulkin, SA Petrov, V Bodenko… - ACS Pharmacology & …, 2024 - europepmc.org
177 Lu-labeled small-molecule prostate-specific membrane antigen (PSMA) targeted tracers
are therapeutic agents for metastatic castration-resistant prostate cancer. Optimizing …
are therapeutic agents for metastatic castration-resistant prostate cancer. Optimizing …
Synthesis and Preclinical Evaluation of Urea-Based Prostate-Specific Membrane Antigen-Targeted Conjugates Labeled with 177Lu
AE Machulkin, SA Petrov, V Bodenko… - ACS pharmacology & …, 2024 - diva-portal.org
177 Lu-labeled small-molecule prostate-specific membrane antigen (PSMA) targeted tracers
are therapeutic agents for metastatic castration-resistant prostate cancer. Optimizing …
are therapeutic agents for metastatic castration-resistant prostate cancer. Optimizing …